Progenics Pharmaceuticals Announces That Data From a Phase I Study of Its 1404 Imaging Agent Has Been Presented at the Society for Urologic Oncology Meeting - Progenics Also Announces That Topline Data From a Recently Completed Phase II Trial of 1404 Will be Presented at ASCO GU in January 2014 TARRYTOWN, N.Y., Dec. 6, 2013 -- Progenics ... (more)
http://www.globenewswire.com/news-release/2013/12/06/595264/10060728/en/Progenics-Pharmaceuticals-Announces-That-Data-From-a-Phase-I-Study-of-Its-1404-Imaging-Agent-Has-Been-Presented-at-the-Society-for-Urologic-Oncology-Meeting.html
http://www.globenewswire.com/news-release/2013/12/06/595264/10060728/en/Progenics-Pharmaceuticals-Announces-That-Data-From-a-Phase-I-Study-of-Its-1404-Imaging-Agent-Has-Been-Presented-at-the-Society-for-Urologic-Oncology-Meeting.html
No comments:
Post a Comment